Could a tiny jolt to the head diagnose balance problems?
NCT ID NCT07267910
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 3 times
Summary
This early study will test whether weak electrical currents applied to the head can help diagnose balance disorders like vestibular schwannoma and vestibular neuritis. Researchers will measure how 30 people with these conditions sway or move in response to the stimulation. The goal is to see if this simple, non-invasive method can reliably detect inner-ear problems and possibly guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- weak alternating-current electrical stimulation (device)
- What this could lead to
- If successful, this could provide a new, non-invasive way to diagnose balance disorders and possibly guide rehabilitation.
- What could go wrong
- This is a very early, small study (30 people) that only tests the method's feasibility. It may not lead to a reliable diagnostic tool or any treatment benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNILATERAL HEARING LOSS AND VESTIBULAR DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dept. of Otorhinolaryngology, HUS Helsinki University Hospital
Helsinki, 00130, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a precise radiation beam spare balance? a study investigates
- Could a symptom registry unmask hidden migraine variants?
- Smart sensors could predict falls in older adults with dizziness
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- Drug combo aims to shrink NF2 tumors and save hearing